Investing in Alliance Pharmaceuticals

At a glance

Our performance highlights 2019

Strong organic growth, driven by our International Star brands and other consumer brands

>90 products

144 £m Annual Revenues (see through basis 2019)

100+ countries where our products are sold

16% See through revenue growth (2019)

55% of revenue from consumer healthcare products (2019)

Results centre

Built for modern business

An inter-connected network of people and brands

A global range of products delivering outstanding value. Many partners working together; one team, achieving more.

A global business

Headquartered in the UK, with affiliated offices in Europe, the Far East and the US

• Wide international reach through an extensive network of distributors
• Sales in more than 100 countries

Our global locations

Our model

Organic growth through our International Star Brands. Additional growth through select acquisitions facilitated by strong cash generation.

• Significant M&A and integration expertise
• More than 35 deals in 20 years

Our business model

Our portfolio

Alliance owns or licenses the rights to more than 90 pharmaceutical and consumer healthcare products

• Limited number of promoted International Star brands
• Supported by a diversified portfolio of cash generative Local brands

Our brands